ÂÜÀòÂÒÂ×

Anat Arbel Shamir has extensive experience in public policy, health system access, and international trade, currently serving as Public Policy Lead at Roche since March 2020. In addition to leading Roche for a Better Future and acting as Health System Public Policy Partner, Anat is involved with WE@HealthTech and the Israel-America Chamber of Commerce as a member of the leadership team for the AmCham Pharma Committee. Previous roles include VP of Access, Regulation & International Affairs at Pharma Israel and various directorial positions within the Foreign Trade Administration of Israel. Anat holds an MBA from The Hebrew University of Jerusalem and dual bachelor's degrees in Economics and International Relations from both The Hebrew University and Vrije Universiteit Brussel.